down arrow

Mettler-Toledo International, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5926881054
USD
1,403.58
-93.03 (-6.22%)

Jan 20

NYS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,401.441,430.50

52 Week

946.691,525.17
Valuation
Technical
Day's Volume

CASH

57.89 k

Shareholding (Mar 2025)

FII

33.53%

Held by 402 FIIs

DII

21.07%

Held by 50 DIIs

Promoter

0.03%

How big is Mettler-Toledo International, Inc.?

22-Jun-2025

As of Jun 18, Mettler-Toledo International, Inc. has a market capitalization of $48.99 billion, with net sales of $3.83 billion and net profit of $849.22 million over the latest four quarters.

As of Jun 18, Mettler-Toledo International, Inc. has a market capitalization of 48,994.88 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 3,830.15 million, while the sum of net profit for the same period is 849.22 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at -126.89 million and total assets amounting to 3,240.00 million.

View full answer

What does Mettler-Toledo International, Inc. do?

22-Jun-2025

Mettler-Toledo International, Inc. is a large-cap supplier of precision instruments and services primarily for the Pharmaceuticals & Biotechnology industry, with a market cap of approximately $49 billion. As of March 2025, it reported net sales of $884 million and a net profit of $164 million.

Overview:<BR>Mettler-Toledo International, Inc. is a supplier of precision instruments and services in the Pharmaceuticals & Biotechnology industry, categorized as a large-cap company.<BR><BR>Financial Snapshot:<BR>- Net Sales: 884 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: 164 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 48,994.88 Million (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 59.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -11.04<BR>- Return on Equity: -466.64%<BR>- Price to Book: -269.23<BR><BR>Contact Details:<BR>- Address: 1900 Polaris Pkwy, COLUMBUS OH: 43240-4035<BR>- Tel: ['1 614 4384511', '1 614 4384748']<BR>- Fax: 1 302 6555049<BR>- Website: https://www.mt.com/

View full answer

Who are in the management team of Mettler-Toledo International, Inc.?

22-Jun-2025

As of March 2022, the management team of Mettler-Toledo International, Inc. includes Independent Chairman Robert Spoerry, President Oliver Filliol, and several Independent Directors: Wah-Hui Chu, Domitille Doat-Le Bigot, Elisha W. Finney, Richard Francis, and Michael Kelly. They oversee the company's strategic direction and governance.

As of March 2022, the management team of Mettler-Toledo International, Inc. includes the following individuals:<BR><BR>- Mr. Robert Spoerry, who serves as the Independent Chairman of the Board.<BR>- Mr. Oliver Filliol, who is the President and a Director.<BR>- Mr. Wah-Hui Chu, who is an Independent Director.<BR>- Ms. Domitille Doat-Le Bigot, who is also an Independent Director.<BR>- Ms. Elisha W. Finney, serving as an Independent Director.<BR>- Mr. Richard Francis, who is an Independent Director.<BR>- Mr. Michael Kelly, who is another Independent Director. <BR><BR>This team is responsible for overseeing the company's strategic direction and governance.

View full answer

Is Mettler-Toledo International, Inc. overvalued or undervalued?

20-Sep-2025

As of May 4, 2023, Mettler-Toledo International, Inc. is considered overvalued with a high P/E ratio of 59 and underperformance against the S&P 500, indicating a shift from an attractive to a risky valuation grade.

As of 4 May 2023, Mettler-Toledo International, Inc. has moved from an attractive to a risky valuation grade, indicating a shift towards being overvalued. The company appears to be overvalued, particularly when considering its P/E ratio of 59, an EV to EBITDA of 43.00, and a PEG ratio of 5.29, which are significantly higher than industry peers. For instance, Edwards Lifesciences Corp. has a P/E of 31.17, while Agilent Technologies, Inc. shows a more reasonable P/E of 27.42, suggesting that Mettler-Toledo's valuation is not justified relative to its competitors.<BR><BR>Moreover, the company's recent performance reflects this valuation concern, as it has underperformed against the S&P 500 across multiple periods, including a 1Y return of -8.24% compared to the S&P 500's 17.14%. This trend reinforces the notion that Mettler-Toledo may be overvalued in the current market environment.

View full answer

Is Mettler-Toledo International, Inc. technically bullish or bearish?

14-Oct-2025

As of October 10, 2025, Mettler-Toledo International, Inc. has a mildly bullish technical trend, supported by positive weekly indicators, despite mixed monthly signals and underperforming the S&P 500 over the past year.

As of 10 October 2025, the technical trend for Mettler-Toledo International, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The daily moving averages are also mildly bullish. However, the Bollinger Bands show a mixed signal with a mildly bullish weekly stance and a mildly bearish monthly stance. The KST is bullish weekly but bearish monthly, and the Dow Theory supports a mildly bullish view on both weekly and monthly time frames. <BR><BR>In terms of performance, the stock has underperformed the S&P 500 over the past year, returning -11.46% compared to the S&P 500's 13.36%, but it has shown a positive return of 2.00% over the last month against the S&P 500's 0.31%. Overall, the current technical stance is mildly bullish, driven by the positive weekly indicators despite some mixed signals in the monthly data.

View full answer

Compare Mettler-Toledo International, Inc. with Similar Stocks

West Pharmaceutical Services, Inc.GE Healthcare Technologies, Inc.Agilent Technologies, Inc.
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Flat results in Jun 25

3

Risky - Negative Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 55,740 Million (Mid Cap)

stock-summary
P/E

59.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-8.20

stock-summary
Return on Equity

-312.94%

stock-summary
Price to Book

-215.39

Revenue and Profits:
Net Sales:
983 Million
(Quarterly Results - Jun 2025)
Net Profit:
202 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.23%
0%
3.23%
6 Months
18.53%
0%
18.53%
1 Year
8.17%
0%
8.17%
2 Years
18.55%
0%
18.55%
3 Years
-9.9%
0%
-9.9%
4 Years
-7.22%
0%
-7.22%
5 Years
15.19%
0%
15.19%

Mettler-Toledo International, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Mettler-Toledo Hits New 52-Week High at $1,454.67

Mettler-Toledo Hits New 52-Week High at $1,454.67

Mettler-Toledo International, Inc. achieved a new 52-week high of USD 1,454.67 on October 24, 2025, contrasting with a low of USD 946.69. The company, with a market cap of approximately USD 55,740 million, faces a one-year performance decline and unique financial metrics in the Pharmaceuticals & Biotechnology industry.

Read full news article

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
5.65%
EBIT Growth (5y)
8.87%
EBIT to Interest (avg)
17.81
Debt to EBITDA (avg)
1.61
Net Debt to Equity (avg)
-11.04
Sales to Capital Employed (avg)
1.96
Tax Ratio
16.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
56.19%
ROE (avg)
634.05%

Valuation key factors

Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
-277.13
EV to EBIT
47.78
EV to EBITDA
43.00
EV to Capital Employed
28.69
EV to Sales
13.69
PEG Ratio
5.29
Dividend Yield
NA
ROCE (Latest)
60.04%
ROE (Latest)
Negative BV

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 154 Schemes (45.33%)

Foreign Institutions

Held by 402 Foreign Institutions (33.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 11.26% vs -15.44% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 23.66% vs -35.16% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "983.20",
          "val2": "883.70",
          "chgp": "11.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "296.20",
          "val2": "249.20",
          "chgp": "18.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.80",
          "val2": "16.70",
          "chgp": "0.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "16.40",
          "val2": "-6.00",
          "chgp": "373.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "202.30",
          "val2": "163.60",
          "chgp": "23.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.20%",
          "val2": "248.40%",
          "chgp": "2.18%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.22% vs -3.35% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.42% vs -9.59% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,872.40",
          "val2": "3,788.30",
          "chgp": "2.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,250.30",
          "val2": "1,200.80",
          "chgp": "4.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "63.20",
          "val2": "88.30",
          "chgp": "-28.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.40",
          "val2": "-25.20",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "863.10",
          "val2": "788.80",
          "chgp": "9.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "291.10%",
          "val2": "285.00%",
          "chgp": "0.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary

Jun'25
Mar'25
Change(%)
Net Sales
983.20
883.70
11.26%
Operating Profit (PBDIT) excl Other Income
296.20
249.20
18.86%
Interest
16.80
16.70
0.60%
Exceptional Items
16.40
-6.00
373.33%
Consolidate Net Profit
202.30
163.60
23.66%
Operating Profit Margin (Excl OI)
270.20%
248.40%
2.18%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 11.26% vs -15.44% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 23.66% vs -35.16% in Mar 2025

All Quarterly Resultsstock-summary

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
3,872.40
3,788.30
2.22%
Operating Profit (PBDIT) excl Other Income
1,250.30
1,200.80
4.12%
Interest
63.20
88.30
-28.43%
Exceptional Items
-8.40
-25.20
66.67%
Consolidate Net Profit
863.10
788.80
9.42%
Operating Profit Margin (Excl OI)
291.10%
285.00%
0.61%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.22% vs -3.35% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 9.42% vs -9.59% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Mettler-Toledo International, Inc. stock-summary
stock-summary
Mettler-Toledo International, Inc.
Pharmaceuticals & Biotechnology
Mettler-Toledo International Inc. is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications. The Company is also a provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. In addition, the Company is also a supplier of end-of-line inspection systems used in production and packaging for food, pharmaceutical and other industries. The Company serves food and beverage producers; food retailers; chemical, specialty chemicals and cosmetics companies, and the transportation and logistics industry, among others.
Company Coordinates stock-summary
Company Details
1900 Polaris Pkwy , COLUMBUS OH : 43240-4035
stock-summary
Tel: 1 614 43845111 614 4384748
stock-summary
https://www.mt.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."